SBFM logo

Sunshine Biopharma (SBFM) Cash From Financing

Annual CFF

$3.43 M
-$36.04 M-91.32%

December 31, 2023

Summary

Performance

1-Year Change

-91.32%

3-Year Change

+113%

5-Year Change

+549.28%

15-Year Change

+410.75%

SBFM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.96%
SBFM annual cash flow from financing activities is higher than 43.96% of companies in Healthcare sector

High & Low

All-time High

$39.47 M
SBFM annual cash flow from financing activities is currently -91.32% below its historical high of $39.47 million

3-Year Low

$2.90 M
SBFM annual cash flow from financing activities is currently +17.93% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SBFM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 20, 2025
SBFM next annual earnings announcement is scheduled for May 20, 2025

OtherSBFMcash flowmetrics:

Annual CFI

-$656.20 K
SBFM annual cash flow from investing activities is -$656.20 thousand

Annual CFO

-$8.78 M
SBFM annual cash flow from operations is -$8.78 million

Annual FCF

-$9.56 M
SBFM annual free cash flow is -$9.56 million

Annual CAPEX

$788.10 K
SBFM annual capital expenditures is $788.10 thousand

Quarterly CFF

$1.87 M
+$1.89 M+6624.48%

September 30, 2024

Summary

Performance

3-Month Change

+6624.48%

1-Year Change

+3033.96%

3-Year Change

-54.02%

5-Year Change

-54.02%

SBFM Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.7%
SBFM quarterly cash flow from financing activities is higher than 69.7% of companies in Healthcare sector

High & Low

All-time High

$29.12 M
SBFM quarterly cash flow from financing activities is currently -93.59% below its historical high of $29.12 million

3-Year Low

-$2.10 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SBFM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 20, 2025
SBFM next earnings announcement is scheduled for May 20, 2025

OtherSBFMcash flowmetrics:

Quarterly CFI

-$578.40 K
SBFM quarterly cash flow from investing activities is -$578.40 thousand

Quarterly CFO

-$1.36 M
SBFM quarterly cash flow from operations is -$1.36 million

Quarterly FCF

-$1.97 M
SBFM quarterly free cash flow is -$1.97 million

Quarterly CAPEX

$609.50 K
SBFM quarterly capital expenditures is $609.50 thousand

TTM CFF

$7.21 M
+$1.93 M+36.58%

September 30, 2024

Summary

Performance

3-Month Change

+36.58%

1-Year Change

+429.86%

3-Year Change

+406.18%

5-Year Change

+406.18%

SBFM TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.99%
SBFM TTM cash flow from financing activities is higher than 47.99% of companies in Healthcare sector

High & Low

All-time High

$42.81 M
SBFM TTM cash flow from financing activities is currently -83.17% below its historical high of $42.81 million

3-Year Low

$1.36 M
SBFM TTM cash flow from financing activities is currently +429.86% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SBFM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 20, 2025
SBFM next earnings announcement is scheduled for May 20, 2025

OtherSBFMcash flowmetrics:

TTM CFI

-$2.06 M
SBFM TTM cash flow from investing activities is -$2.06 million

TTM CFO

-$11.81 M
SBFM TTM cash flow from operations is -$11.81 million

TTM FCF

-$14.00 M
SBFM TTM free cash flow is -$14.00 million

TTM CAPEX

$2.19 M
SBFM TTM capital expenditures is $2.19 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

SBFM Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-91.3%+3034.0%+429.9%
3 y3 years+113.0%-54.0%+406.2%
5 y5 years+549.3%-54.0%+406.2%

SBFM Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-91.3%+17.9%-93.6%+189.0%-83.2%+429.9%
5 y5-year-91.3%+674.5%-93.6%+189.0%-83.2%+3064.3%
alltimeall time-91.3%>+9999.0%-93.6%+189.0%-83.2%-100.0%

Sunshine Biopharma Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.87 M(-6624.5%)
$7.21 M(+36.6%)
Jun 2024
-
-$28.60 K(-100.5%)
$5.28 M(-43.7%)
Mar 2024
-
$5.40 M(<-9900.0%)
$9.36 M(+173.3%)
Dec 2023
$3.43 M(-91.3%)
-$30.50 K(-52.0%)
$3.43 M(+151.9%)
Sep 2023
-
-$63.60 K(-101.6%)
$1.36 M(-4.5%)
Jun 2023
-
$4.06 M(-853.9%)
$1.42 M(-94.6%)
Mar 2023
-
-$538.30 K(-74.3%)
$26.49 M(-32.9%)
Dec 2022
$39.47 M(+1258.7%)
-$2.10 M(<-9900.0%)
$39.47 M(-5.0%)
Sep 2022
-
$0.00(-100.0%)
$41.54 M(-3.0%)
Jun 2022
-
$29.12 M(+134.2%)
$42.81 M(+200.6%)
Mar 2022
-
$12.44 M(<-9900.0%)
$14.24 M(+390.3%)
Dec 2021
$2.90 M(+80.6%)
-
-
Dec 2021
-
-$23.70 K(-101.9%)
$2.90 M(-24.6%)
Sep 2021
-
$1.28 M(+131.7%)
$3.85 M(+24.2%)
Jun 2021
-
$550.60 K(-50.0%)
$3.10 M(+14.4%)
Mar 2021
-
$1.10 M(+19.2%)
$2.71 M(+68.5%)
Dec 2020
$1.61 M(+263.6%)
$924.60 K(+76.2%)
$1.61 M(+107.8%)
Sep 2020
-
$524.60 K(+229.9%)
$773.80 K(+102.6%)
Jun 2020
-
$159.00 K(>+9900.0%)
$381.90 K(+67.7%)
Mar 2020
-
$0.00(-100.0%)
$227.70 K(-48.5%)
Dec 2019
$442.30 K(-16.2%)
$90.20 K(-32.0%)
$442.40 K(-15.7%)
Sep 2019
-
$132.70 K(+2664.6%)
$525.00 K(+8.5%)
Jun 2019
-
$4800.00(-97.8%)
$484.00 K(-2.0%)
Mar 2019
-
$214.70 K(+24.2%)
$493.80 K(-6.4%)
Dec 2018
$527.60 K(-21.3%)
$172.80 K(+88.4%)
$527.70 K(-7.3%)
Sep 2018
-
$91.70 K(+528.1%)
$569.10 K(-13.6%)
Jun 2018
-
$14.60 K(-94.1%)
$658.30 K(-22.8%)
Mar 2018
-
$248.60 K(+16.1%)
$853.10 K(+27.2%)
Dec 2017
$670.70 K(+106.6%)
$214.20 K(+18.4%)
$670.70 K(+27.6%)
Sep 2017
-
$180.90 K(-13.6%)
$525.80 K(+47.7%)
Jun 2017
-
$209.40 K(+216.3%)
$356.10 K(+57.1%)
Mar 2017
-
$66.20 K(-4.5%)
$226.70 K(-30.2%)
Dec 2016
$324.60 K
$69.30 K(+518.8%)
$324.60 K(-71.7%)
Sep 2016
-
$11.20 K(-86.0%)
$1.15 M(-5.2%)
Jun 2016
-
$80.00 K(-51.2%)
$1.21 M(-16.2%)
DateAnnualQuarterlyTTM
Mar 2016
-
$164.10 K(-81.6%)
$1.44 M(+3.3%)
Dec 2015
$1.40 M(+114.9%)
$893.10 K(+1110.2%)
$1.40 M(+93.5%)
Sep 2015
-
$73.80 K(-76.5%)
$722.80 K(-9.9%)
Jun 2015
-
$313.40 K(+164.9%)
$802.50 K(+25.6%)
Mar 2015
-
$118.30 K(-45.6%)
$639.10 K(-1.8%)
Dec 2014
$650.80 K(+40.6%)
$217.30 K(+41.6%)
$650.80 K(+50.1%)
Sep 2014
-
$153.50 K(+2.3%)
$433.50 K(+54.8%)
Jun 2014
-
$150.00 K(+15.4%)
$280.00 K(+115.4%)
Mar 2014
-
$130.00 K(>+9900.0%)
$130.00 K(-71.9%)
Dec 2013
$463.00 K(-0.4%)
$0.00(0.0%)
$463.00 K(-9.7%)
Sep 2013
-
$0.00(0.0%)
$513.00 K(-40.7%)
Jun 2013
-
$0.00(-100.0%)
$865.50 K(-5.5%)
Mar 2013
-
$463.00 K(+826.0%)
$915.50 K(+96.9%)
Dec 2012
$465.00 K(+137.7%)
$50.00 K(-85.8%)
$465.00 K(+12.0%)
Sep 2012
-
$352.50 K(+605.0%)
$415.00 K(+60.8%)
Jun 2012
-
$50.00 K(+300.0%)
$258.10 K(+24.0%)
Mar 2012
-
$12.50 K(>+9900.0%)
$208.10 K(+6.4%)
Dec 2011
$195.60 K(-50.9%)
$0.00(-100.0%)
$195.60 K(-60.4%)
Sep 2011
-
$195.60 K(>+9900.0%)
$494.20 K(+24.0%)
Jun 2011
-
$0.00(0.0%)
$398.60 K(0.0%)
Mar 2011
-
$0.00(-100.0%)
$398.60 K(0.0%)
Dec 2010
$398.60 K(-38.6%)
$298.60 K(+198.6%)
$398.60 K(+298.6%)
Sep 2010
-
$100.00 K(>+9900.0%)
$100.00 K(-84.6%)
Jun 2010
-
$0.00(0.0%)
$649.00 K(-0.2%)
Mar 2010
-
$0.00(-100.0%)
$650.50 K(-0.2%)
Dec 2009
$649.00 K(+9884.6%)
-
-
Oct 2009
-
$649.00 K(>+9900.0%)
$652.00 K(>+9900.0%)
Jul 2009
$6500.00(-48.0%)
$1500.00(0.0%)
$6500.00(-13.3%)
Apr 2009
-
$1500.00(>+9900.0%)
$7500.00(-53.1%)
Jan 2009
-
$0.00(-100.0%)
$16.00 K(0.0%)
Oct 2008
-
$3500.00(+40.0%)
$16.00 K(+28.0%)
Jul 2008
$12.50 K(-30.6%)
$2500.00(-75.0%)
$12.50 K(+25.0%)
Apr 2008
-
$10.00 K(>+9900.0%)
$10.00 K(>+9900.0%)
Jan 2008
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2007
-
$0.00
$0.00
Jul 2007
$18.00 K
-
-

FAQ

  • What is Sunshine Biopharma annual cash flow from financing activities?
  • What is the all time high annual CFF for Sunshine Biopharma?
  • What is Sunshine Biopharma annual CFF year-on-year change?
  • What is Sunshine Biopharma quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Sunshine Biopharma?
  • What is Sunshine Biopharma quarterly CFF year-on-year change?
  • What is Sunshine Biopharma TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Sunshine Biopharma?
  • What is Sunshine Biopharma TTM CFF year-on-year change?

What is Sunshine Biopharma annual cash flow from financing activities?

The current annual CFF of SBFM is $3.43 M

What is the all time high annual CFF for Sunshine Biopharma?

Sunshine Biopharma all-time high annual cash flow from financing activities is $39.47 M

What is Sunshine Biopharma annual CFF year-on-year change?

Over the past year, SBFM annual cash flow from financing activities has changed by -$36.04 M (-91.32%)

What is Sunshine Biopharma quarterly cash flow from financing activities?

The current quarterly CFF of SBFM is $1.87 M

What is the all time high quarterly CFF for Sunshine Biopharma?

Sunshine Biopharma all-time high quarterly cash flow from financing activities is $29.12 M

What is Sunshine Biopharma quarterly CFF year-on-year change?

Over the past year, SBFM quarterly cash flow from financing activities has changed by +$1.93 M (+3033.96%)

What is Sunshine Biopharma TTM cash flow from financing activities?

The current TTM CFF of SBFM is $7.21 M

What is the all time high TTM CFF for Sunshine Biopharma?

Sunshine Biopharma all-time high TTM cash flow from financing activities is $42.81 M

What is Sunshine Biopharma TTM CFF year-on-year change?

Over the past year, SBFM TTM cash flow from financing activities has changed by +$5.85 M (+429.86%)